Daniel W. Golden
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Daniel W. Golden has a total of 267 co-authors. Here are the top co-authors by number of shared publications:
Steven J. Chmura
Department of Radiation and Cellular Oncology, University of Chicago, Chicago, Illinois
8 shared publicationsJillian R. Gunther
Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas
6 shared publicationsRachel B. Jimenez
Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts
6 shared publicationsSteve Braunstein
University of California San Francisco, San Francisco, USA
6 shared publicationsCharles R. Thomas
Department of Radiation Medicine, Oregon Health & Science University, Portland, Oregon
5 shared publicationsErin F. Gillespie
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York
5 shared publications
Latest Publications
- Top Cited Papers
- 1 April 2026
- Published by American Society of Clinical Oncology (ASCO) in JCO Oncology Practice
- Vol. 22 (4) , 675-685
Longitudinal Associations Between Financial Toxicity and Health-Related Quality of Life for Patients With Cancer
PURPOSE: Evaluate the longitudinal relationship between financial toxicity (FT), health-related quality of life (HR-QOL), and psychological distress for patients with cancer. METHODS: Adults with cancer applying for foundation financial assistance or receiving treatment participated in a longitudinal survey study at any point in their cancer journey and 1, 3, and 6 months later. Validated surveys measured FT (Comprehensive Score for FT [COST]), HR-QOL (Functional Assessment of Cancer Therapy-General [FACT-G]), and psychological distress (Brief-Profile of Mood States [Brief-POMS]). Multilevel ordinal logistic and linear regression models assessed longitudinal relationships. RESULTS: Out of 1,112 approached, 732 (66%) completed the enrollment survey with subsequent response rates of 66%, 58%, and 52% at 1, 3, and 6 months, respectively. Participants had a mean age of 68 years. Most were non-Hispanic White (86%), male (57%), Medicare beneficiaries (82%), and had hematologic malignancies (53%). Most common cancer types were multiple myeloma and prostate cancer. Most (80%) had FT at enrollment (grade 1+ or COST <26), and FT was higher in earlier calendar months. Access to a financial counselor was associated with lower FT for those who desired a referral (adjusted odds ratio [aOR], 0.18). Previous (OR, 1.58) and current (OR, 1.73) intravenous chemotherapy were associated with higher FT. In multivariable multilevel models clustered by participants, higher FT was significantly associated with lower HR-QOL and greater psychological distress. The probability of any FT decreased from 79% at enrollment to 72% at 1 month and 68% at 3 and 6 months. CONCLUSION: Patients with various cancer types had associations between higher FT, lower HR-QOL, and more psychological distress across repeated measures over 6-month intervals. FT screening should be repeated across the cancer care continuum, especially early in the calendar year. This will allow interventions to improve patients' emotional and physical well-being.
- 1 April 2026
- Published by American Society of Clinical Oncology (ASCO) in JCO Oncology Practice
- Vol. 22 (4) , 675-685
Top Cited PapersLongitudinal Associations Between Financial Toxicity and Health-Related Quality of Life for Patients With Cancer
PURPOSE: Evaluate the longitudinal relationship between financial toxicity (FT), health-related quality of life (HR-QOL), and psychological distress for patients with cancer. METHODS: Adults with cancer applying for foundation financial assistance or receiving treatment participated in a longitudinal survey study at any point in their cancer journey and 1, 3, and 6 months later. Validated surveys measured FT (Comprehensive Score for FT [COST]), HR-QOL (Functional Assessment of Cancer Therapy-General [FACT-G]), and psychological distress (Brief-Profile of Mood States [Brief-POMS]). Multilevel ordinal logistic and linear regression models assessed longitudinal relationships. RESULTS: Out of 1,112 approached, 732 (66%) completed the enrollment survey with subsequent response rates of 66%, 58%, and 52% at 1, 3, and 6 months, respectively. Participants had a mean age of 68 years. Most were non-Hispanic White (86%), male (57%), Medicare beneficiaries (82%), and had hematologic malignancies (53%). Most common cancer types were multiple myeloma and prostate cancer. Most (80%) had FT at enrollment (grade 1+ or COST <26), and FT was higher in earlier calendar months. Access to a financial counselor was associated with lower FT for those who desired a referral (adjusted odds ratio [aOR], 0.18). Previous (OR, 1.58) and current (OR, 1.73) intravenous chemotherapy were associated with higher FT. In multivariable multilevel models clustered by participants, higher FT was significantly associated with lower HR-QOL and greater psychological distress. The probability of any FT decreased from 79% at enrollment to 72% at 1 month and 68% at 3 and 6 months. CONCLUSION: Patients with various cancer types had associations between higher FT, lower HR-QOL, and more psychological distress across repeated measures over 6-month intervals. FT screening should be repeated across the cancer care continuum, especially early in the calendar year. This will allow interventions to improve patients' emotional and physical well-being.
- 10 February 2026
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 124 (3) , 588-594
After Burnout: Reigniting the Flame
- 10 February 2026
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 124 (3) , 588-594
After Burnout: Reigniting the Flame
- 5 August 2025
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 123 (5) , 1222-1229
Radiation Therapy Patient Education: A Scoping Review to Identify Future Directions for Scholarship
- 5 August 2025
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 123 (5) , 1222-1229
Radiation Therapy Patient Education: A Scoping Review to Identify Future Directions for Scholarship
- Open Access
- 1 January 2025
- Published by Wiley in Case Reports in Oncological Medicine
- Vol. 2025 (1)
Definitive Chemoradiation for Unresectable Hyalinizing Clear Cell Carcinoma of the Base of the Tongue: A Molecularly Confirmed Case
Hyalinizing clear cell carcinoma (HCCC) is a rare malignancy of the minor salivary glands, most often managed by surgical resection. We report a case of a 63‐year‐old woman with an unresectable base‐of‐tongue tumor initially presumed to be squamous cell carcinoma. Histopathologic evaluation and molecular testing ultimately confirmed HCCC with an EWSR1‐ATF1 fusion. Given the tumor’s extent, she was treated with definitive chemoradiation using weekly cisplatin and 70 Gy in 35 fractions. Her course was complicated by pulmonary embolism, neutropenia, and severe mucositis requiring percutaneous endoscopic gastrostomy tube placement. Post‐treatment imaging showed decreased FDG avidity, and circulating tumor DNA remained negative for minimal residual disease. This case highlights the importance of molecular diagnostics in distinguishing HCCC from other clear cell neoplasms and suggests a potential role for chemoradiation in unresectable cases, though treatment‐related toxicity remains a significant concern. Further investigation into systemic and targeted therapies for HCCC is warranted.
- 1 January 2025
- Published by Wiley in Case Reports in Oncological Medicine
- Vol. 2025 (1)
Open AccessDefinitive Chemoradiation for Unresectable Hyalinizing Clear Cell Carcinoma of the Base of the Tongue: A Molecularly Confirmed Case
Hyalinizing clear cell carcinoma (HCCC) is a rare malignancy of the minor salivary glands, most often managed by surgical resection. We report a case of a 63‐year‐old woman with an unresectable base‐of‐tongue tumor initially presumed to be squamous cell carcinoma. Histopathologic evaluation and molecular testing ultimately confirmed HCCC with an EWSR1‐ATF1 fusion. Given the tumor’s extent, she was treated with definitive chemoradiation using weekly cisplatin and 70 Gy in 35 fractions. Her course was complicated by pulmonary embolism, neutropenia, and severe mucositis requiring percutaneous endoscopic gastrostomy tube placement. Post‐treatment imaging showed decreased FDG avidity, and circulating tumor DNA remained negative for minimal residual disease. This case highlights the importance of molecular diagnostics in distinguishing HCCC from other clear cell neoplasms and suggests a potential role for chemoradiation in unresectable cases, though treatment‐related toxicity remains a significant concern. Further investigation into systemic and targeted therapies for HCCC is warranted.
- 14 April 2023
- Published by Springer Nature in Journal of Cancer Education
- Vol. 38 (5) , 1501-1508
Adapting a Medical School Cancer Research Education Program to the Virtual Environment: a Mixed-Methods Study
With cancer incidence increasing worldwide, physicians with cancer research training are needed. The Scholars in Oncology-Associated Research (SOAR) cancer research education program was developed to train medical students in cancer research while exposing them to the breadth of clinical oncology. Due to the COVID-19 pandemic, SOAR transitioned from in-person in 2019 to virtual in 2020 and hybrid in 2021. This study investigates positive and negative aspects of the varying educational formats. A mixed-methods approach was used to evaluate the educational formats. Pre- and post-surveys were collected from participants to assess their understanding of cancer as a clinical and research discipline. Structured interviews were conducted across all three cohorts, and thematic analysis was used to generate themes. A total of 37 students participated in SOAR and completed surveys (2019 n = 11, 2020 n = 14, and 2021 n = 12), and 18 interviews were conducted. Understanding of oncology as a clinical (p < 0.01 for all) and research discipline (p < 0.01 for all) improved within all three cohorts. There was no difference between each cohort’s improvement in research understanding (p = 0.6). There was no difference between each cohort’s understanding of oncology-related disciplines as both clinical and research disciplines (p > 0.1 for all). Thematic analysis demonstrated that hybrid and in-person formats were favored over a completely virtual one. Our findings demonstrate that a medical student cancer research education program is effective using in-person or hybrid formats for research education, although virtual experiences may be suboptimal to learning about clinical oncology.
- 14 April 2023
- Published by Springer Nature in Journal of Cancer Education
- Vol. 38 (5) , 1501-1508
Adapting a Medical School Cancer Research Education Program to the Virtual Environment: a Mixed-Methods Study
With cancer incidence increasing worldwide, physicians with cancer research training are needed. The Scholars in Oncology-Associated Research (SOAR) cancer research education program was developed to train medical students in cancer research while exposing them to the breadth of clinical oncology. Due to the COVID-19 pandemic, SOAR transitioned from in-person in 2019 to virtual in 2020 and hybrid in 2021. This study investigates positive and negative aspects of the varying educational formats. A mixed-methods approach was used to evaluate the educational formats. Pre- and post-surveys were collected from participants to assess their understanding of cancer as a clinical and research discipline. Structured interviews were conducted across all three cohorts, and thematic analysis was used to generate themes. A total of 37 students participated in SOAR and completed surveys (2019 n = 11, 2020 n = 14, and 2021 n = 12), and 18 interviews were conducted. Understanding of oncology as a clinical (p < 0.01 for all) and research discipline (p < 0.01 for all) improved within all three cohorts. There was no difference between each cohort’s improvement in research understanding (p = 0.6). There was no difference between each cohort’s understanding of oncology-related disciplines as both clinical and research disciplines (p > 0.1 for all). Thematic analysis demonstrated that hybrid and in-person formats were favored over a completely virtual one. Our findings demonstrate that a medical student cancer research education program is effective using in-person or hybrid formats for research education, although virtual experiences may be suboptimal to learning about clinical oncology.
- 19 January 2023
- Published by Elsevier in Brachytherapy
- Vol. 22 (3) , 352-360
Communicating the Gynecologic Brachytherapy Experience (CoGBE): Clinician perceived benefits of a graphic narrative discussion guide
- 19 January 2023
- Published by Elsevier in Brachytherapy
- Vol. 22 (3) , 352-360
Communicating the Gynecologic Brachytherapy Experience (CoGBE): Clinician perceived benefits of a graphic narrative discussion guide
- 1 June 2021
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 110 (2) , 292-302
Mentorship Initiatives in Radiation Oncology: A Scoping Review of the Literature
- 1 June 2021
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 110 (2) , 292-302
Mentorship Initiatives in Radiation Oncology: A Scoping Review of the Literature
- 1 June 2021
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 110 (2) , 315-321
The Radiation Oncology Education Collaborative Study Group 2020 Spring Symposium: Is Virtual the New Reality?
- 1 June 2021
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 110 (2) , 315-321
The Radiation Oncology Education Collaborative Study Group 2020 Spring Symposium: Is Virtual the New Reality?
- 26 May 2021
- Published by Springer Nature
- p. 157-167
Becoming an Educator: Giving Feedback, Supervising Trainees, Formal Didactics
- 26 May 2021
- Published by Springer Nature
- p. 157-167
Becoming an Educator: Giving Feedback, Supervising Trainees, Formal Didactics